{"DataElement":{"publicId":"14510657","version":"1","preferredName":"Carmustine Implant Completion Date","preferredDefinition":"The date Gliadel Wafers implantation was complete.","longName":"14510656v1.00:3113414v1.00","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"14510656","version":"1","preferredName":"Carmustine Implant Completion Date","preferredDefinition":"A synthetic, biodegradable wafer containing the agent carmustine with antineoplastic activity. Used to deliver drug directly into a brain tumor site and typically implanted post-surgically, the wafer is made of a biodegradable poly-anhydride copolymer and contains the nitrosourea carmustine.  As an antineoplastic nitrosourea, carmustine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis.  Carmustine also carbamoylates proteins, including DNA repair enzymes, resulting in an enhanced cytotoxic effect.  Carmustine is highly lipophilic and crosses the blood-brain barrier readily. (NCI04):The date on which the activity or entity is finished.","longName":"14510655v1.00:7665042v1.00","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"14510655","version":"1","preferredName":"Carmustine Implant","preferredDefinition":"A synthetic, biodegradable wafer containing the agent carmustine with antineoplastic activity. Used to deliver drug directly into a brain tumor site and typically implanted post-surgically, the wafer is made of a biodegradable poly-anhydride copolymer and contains the nitrosourea carmustine.  As an antineoplastic nitrosourea, carmustine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis.  Carmustine also carbamoylates proteins, including DNA repair enzymes, resulting in an enhanced cytotoxic effect.  Carmustine is highly lipophilic and crosses the blood-brain barrier readily. (NCI04)","longName":"C2487","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carmustine Implant","conceptCode":"C2487","definition":"A synthetic, biodegradable wafer containing the agent carmustine with antineoplastic activity. Used to deliver drug directly into a brain tumor site and typically implanted post-surgically, the wafer is made of a biodegradable poly-anhydride copolymer and contains the nitrosourea carmustine.  As an antineoplastic nitrosourea, carmustine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis.  Carmustine also carbamoylates proteins, including DNA repair enzymes, resulting in an enhanced cytotoxic effect.  Carmustine is highly lipophilic and crosses the blood-brain barrier readily. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0661E3F0-4FF3-5022-E063-731AD00A4A8D","latestVersionIndicator":"Yes","beginDate":"2023-09-27","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-09-27","modifiedBy":"GDEEN","dateModified":"2023-09-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7665042","version":"1","preferredName":"Completion Date","preferredDefinition":"The date on which the activity or entity is finished.","longName":"C164472","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Completion Date","conceptCode":"C164472","definition":"The date on which the activity or entity is finished.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C288502D-719E-119E-E053-4EBD850A9CA4","latestVersionIndicator":"Yes","beginDate":"2021-05-17","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-05-17","modifiedBy":"ONEDATA","dateModified":"2021-05-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008561","version":"1","preferredName":"Occurrences","preferredDefinition":"dates, times, and durations.","longName":"OCURS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53BD1AB-090B-398B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-01-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0661E3F0-4FF4-5022-E063-731AD00A4A8D","latestVersionIndicator":"Yes","beginDate":"2023-09-27","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-09-27","modifiedBy":"GDEEN","dateModified":"2023-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3113414","version":"1","preferredName":"Completion Date","preferredDefinition":"To possess every necessary or normal part or component or step; having come or been brought to a conclusion. (NCI)_a particular day specified as the time something has, or will, happen.","longName":"COMPL_DT","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"DATE","minLength":null,"maxLength":"6","minValue":null,"maxValue":null,"decimalPlace":null,"format":"mm/dd/yy","PermissibleValues":[],"ConceptualDomain":{"publicId":"2524082","version":"1","preferredName":"Person Measure/Instrument Testing","preferredDefinition":"Process and results associated with self-reported measures and instruments, surveys, other tools","longName":"MEASURE/INSTRUMENT TESTING","context":"CCR","contextVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E838B40-6636-0A25-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-09-28","modifiedBy":"REEVESD","dateModified":"2008-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2436883","version":"1","preferredName":"Complete Date","preferredDefinition":"Complete; having every necessary or normal part or component or step; or having come or been brought to a conclusion.:a particular day specified as the time something has, or will, happen.","longName":"C25250:C25164","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete","conceptCode":"C25250","definition":"To possess every necessary or normal part or component or step; having come or been brought to a conclusion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Date","conceptCode":"C25164","definition":"The particular day, month and year an event has happened or will happen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"07CFEE0B-AFA0-3396-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-12-13","modifiedBy":"ONEDATA","dateModified":"2005-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MMQL: Minneapolis-Manchester QOL Survey of Health","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89A31591-6CF3-AE55-E040-BB89AD432CE8","latestVersionIndicator":"Yes","beginDate":"2010-06-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-06-22","modifiedBy":"COOPERM","dateModified":"2010-08-31","changeDescription":"6/22/10 Created for MMQL data element. mc 8/31/2010 released VD per D. Reeves request. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Gliadel Wafers completion date","url":null,"context":"Alliance"},{"name":"Alliance text 1","type":"Alternate Question Text","description":"Gliadel Wafers Completion Date","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0661F8BC-1CED-53F6-E063-731AD00A8B14","latestVersionIndicator":"Yes","beginDate":"2023-09-27","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-09-27","modifiedBy":"ZHWENDY","dateModified":"2023-10-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}